Issue of Ordinary Shares, TVR, PDMR Shareholding

RNS Number : 1503A

Arix Bioscience Plc

22 December 2017

Arix Bioscience plc

Issue of Ordinary Shares, Total Voting Rights and Director/PDMR Shareholding Notifications

Arix Bioscience plc (the "Company") announces that it has allotted New Ordinary Shares to two non-executive directors, in accordance with the compensation agreed at their appointments, as follows:

Name of executive director		Number of shares allotted
Meghan FitzGerald		30,344
Giles Kerr		31,663

Application has been made for the 62,007 New Ordinary Shares to be admitted to the standard segment of the Official List and to trading on the Main Market of the London Stock Exchange. The new Ordinary Shares will rank pari passu with the existing ordinary shares and it is expected that admission of these New Ordinary Shares will take place at 8.00 a.m. on 28 December 2017.

Following the issue of 62,007 shares the Company will have a total of 96,153,090 ordinary shares of £0.00001 each in issue and a total number of voting rights in the Company of 96,153,090. The above figure of 96,153,090 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Meghan FitzGerald
2	Reason for the notification
a)	Position / status	Non Executive Director
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of Ordinary Shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£1.895	30,344
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	21 December 2017
f)	Place of the transaction	London Stock Exchange (XLON)

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Giles Kerr
2	Reason for the notification
a)	Position / status	Non Executive Director
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Award of Ordinary Shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		£1.895	31,663
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	21 December 2017
f)	Place of the transaction	London Stock Exchange (XLON)